Our study proved that mir-34a functions as an anti-metastatic microRNA and suppresses angiogenesis by directly targeting CD44 in bladder cancer and subsequently suppress CD44 that regulates transcription of a variety of genes in bladder cancer cells. This evidence concerns the gene CD44 and urinary bladder carcinoma.